Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 2r. Annual reported cases* of notifiable diseases, by region and reporting area, United States, U.S. Territories, and Non-U.S. Residents, 2022
Reporting Area Vancomycin-intermediate Staphylococcus aureus Vancomycin-resistant Staphylococcus aureus § Varicella morbidity Varicella mortality Vibriosis
Total Confirmed Probable
U.S. Residents, excluding U.S. Territories 82 2 4,348 3 3,038 1,474 1,564
New England 4 303 184 121 63
Connecticut 3 68 52 27 25
Maine 41 12 9 3
Massachusetts 1 101 N 101 72 29
New Hampshire N 34 7 4 3
Rhode Island 42 12 9 3
Vermont 17
Middle Atlantic 16 444 463 166 297
New Jersey 3 204 114 44 70
New York (excluding New York City) 9 N N 133 53 80
New York City N N 141 41 100
Pennsylvania 4 240 75 28 47
East North Central 11 1,021 254 94 160
Illinois 2 240 79 28 51
Indiana N 157 24 16 8
Michigan 3 231 44 16 28
Ohio 4 231 N 58 15 43
Wisconsin 2 162 49 19 30
West North Central 32 1 409 157 45 112
Iowa N N N N N
Kansas 1 102 15 15
Minnesota 204 91 20 71
Missouri 32 64 25 16 9
Nebraska 7 16 4 12
North Dakota 18 6 2 4
South Dakota 14 4 3 1
South Atlantic 3 1,021 779 435 344
Delaware 8 12 10 2
District of Columbia N N 10 7 1 6
Florida 428 321 233 88
Georgia 169 88 25 63
Maryland N 109 42 67
North Carolina 1 98 84 37 47
South Carolina 155 38 25 13
Virginia 153 N 101 55 46
West Virginia 2 N 19 7 12
East South Central 9 123 144 61 83
Alabama 1 73 41 20 21
Kentucky N N 29 28 7 21
Mississippi 5 21 N 44 21 23
Tennessee 3 N 31 13 18
West South Central 7 1 547 2 338 155 183
Arkansas 51 N 14 6 8
Louisiana 2 1 48 1 99 46 53
Oklahoma N N 11 5 6
Texas 5 448 1 214 98 116
Mountain 414 1 201 99 102
Arizona 122 1 78 38 40
Colorado 139 N 74 35 39
Idaho N N N N N N N
Montana 22 8 5 3
Nevada 3 9 6 3
New Mexico N N 40 N 4 2 2
Utah 85 21 9 12
Wyoming 3 N 7 4 3
Pacific 66 518 298 220
Alaska N 32 7 4 3
California N N 19 331 175 156
Hawaii 15 43 41 2
Oregon N N N N 34 23 11
Washington N N 103 55 48
U.S. Territories 53 4 3 1
American Samoa N N N N N N N
Commonwealth of Northern Mariana Islands
Guam 10 4 3 1
Puerto Rico 37
U.S. Virgin Islands 6
Non-U.S. Residents
Total 82 2 4,401 3 3,042 1,477 1,565
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • U: Unavailable — The data are unavailable.
  • * Cases are assigned to the reporting jurisdiction submitting the case to NNDSS if the case's country of usual residence is the United States, a U.S. territory, unknown, or country is not reported; otherwise, the case is assigned to the Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions because this data element is only available in the HL7 generic version 2 and disease-specific message mapping guides. If a jurisdiction sends data in legacy formats, they are not able to send this information. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † To calculate rates, use the populations provided in Table 8. Note that calculation of rates for the following conditions uses population subgroups as described in note #7 and population counts presented in Table 8: Zika virus infection, congenital; Zika virus disease, congenital; Infant botulism; Congenital rubella syndrome; Perinatal Hepatitis B infection; Perinatal Hepatitis C infection; Haemophilus influenzae, invasive disease; Invasive pneumococcal disease; and Influenza-associated pediatric mortality. Also see Notes #3 and #7.
  • § Vancomycin-resistant Staphylococcus aureus cases reported in this table may not have been verified by CDC. CDC verified 0 vancomycin-resistant Staphylococcus aureus cases in 2022.